Home > Category > Signaling Pathways > Metabolism > Glucosylceramide Synthase > Miglustat Hydrochloride (N-Butyldeoxynojirimycin Hydrochloride; NB-DNJ hydrochloride; OGT918 hydrochloride)

Miglustat Hydrochloride (N-Butyldeoxynojirimycin Hydrochloride; NB-DNJ hydrochloride; OGT918 hydrochloride)

ChemLeader 98+%

Catalog No：CL1027A CAS No.：210110-90-0 MDLNo： Formula：C10H21NO4.HCl MW：255.74

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Certificate Of Authenticity(CPA)

Download COA

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Miglustat Hydrochloride (N-Butyldeoxynojirimycin Hydrochloride; NB-DNJ hydrochloride; OGT918 hydrochloride)
CAS	210110-90-0
Formula	C10H21NO4.HCl
MW	255.74
Appearance	White to light brown
Storage condition	Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years).

Product details

Miglustat, also known as OGT 918 and NB-DNJ, is a drug developed by Actelion and is used primarily to treat Type I Gaucher disease (GD1). Miglustat inhibits glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids (it forms glucosylceramide and accumulates within the macrophages).

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL1027A

Miglustat Hydrochloride (N-Butyldeoxynojirimycin Hydrochloride; NB-DNJ hydrochloride; OGT918 hydrochloride)

210110-90-0 98+%